According to the results of our study, AFP ≥ 1000 ng/mL is not an independent risk factor for recurrence of hepatoblastoma (AFP < 1000 ng/mL as reference), and there was no significant difference in RFS rates. This evidence concerns the gene AFP and hepatoblastoma.